Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 lineages circulating in Brazil

Several COVID-19 vaccines have shown good efficacy in clinical trials, but there remains uncertainty about the efficacy of vaccines against different variants. Here, we investigate the efficacy of ChAdOx1 nCoV-19 (AZD1222) against symptomatic COVID-19 in a post-hoc exploratory analysis of a Phase 3...

Full description

Bibliographic Details
Main Author: Clemens, Sue Ann Costa (author)
Other Authors: Folegatti, Pedro M. (author), Emary, Katherine R. W. (author), Weckx, Lily Yin (author), Ratcliff, Jeremy (author), Bibi, Sagida (author), Sprinz, Eduardo (author), Pollard, Andrew J. (author), Oxford COVID Vaccine Trial Group (author)
Format: other article
Language:eng
Published: 2022
Subjects:
Doenças transmissíveis
SARS-CoV-2
COVID-19
Vacinas contra COVID-19
Carga viral
Infectious diseases
Vaccines
Viral infection
Online Access:http://hdl.handle.net/10183/236682
Country:Brazil
Oai:oai:www.lume.ufrgs.br:10183/236682

Internet

http://hdl.handle.net/10183/236682

Similar Items